HEERLEN, Netherlands, March 10, 2014 (GLOBE NEWSWIRE) -- Geraldine Matchett is currently the Global Chief Financial Officer and member of the Operations Council of the SGS Group, a publicly quoted company on the SIX Swiss stock exchange and the world leading company in inspection, verification, testing and certification with 80,000 employees and annual revenues of approximately CHF 6 billion.
Geraldine has three nationalities (Swiss, British and French) and has previously worked in London for KPMG and in Switzerland for Deloitte as financial auditor and audit manager, handling clients in the food, pharma and chemical sectors. She has extensive experience with interaction with all relevant stakeholders, has been actively involved in corporate development activities and has managed many areas of the finance function across the world. She was recently voted CFO of the year in Switzerland for large companies.
Rolf-Dieter Schwalb has been the DSM CFO for 8 years, during which the company completed its transformation into a Life Sciences and Materials Sciences company. He will step down as CFO as of December 1, but he will remain available for assistance till 2014 financial closing. The members of the DSM Managing Board and Supervisory Board wish to thank Mr. Schwalb for his contribution to DSM, his leadership in the finance area and his drive for integrated reporting and increased transparency. He has also been very instrumental in the shifts in DSM's portfolio, where his background brought fresh perspectives to the table.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 24,500 employees deliver annual net sales of around €10 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
DSM Corporate Communications Herman Betten
tel. +31 (0) 45 5782017
DSM Investor Relations Dave Huizing
tel. +31 (0) 45 5782864